Clinical UpdatesDrug News

More and more American adolescents are getting recommended vaccines, according to a survey by the Centers for Disease Control and… »   

Researchers at Albert Einstein College of Medicine of Yeshiva University report in the September 4 online edition of Nature Medicine… »   

An experimental stroke preventer from Bayer and Johnson & Johnson is likely to win a recommendation from U.S. health advisers… »   

U.S. regulators and the drug industry want to extend by two months the deadline for the Food and Drug Administration… »   

An investigation into the mysterious inner workings of the malaria parasite has revealed that it survives and proliferates in the… »   

Drug manufacturer Regeneron is in a holding pattern.

Regeneron was hoping to get the green light for a new drug… »   

Powerful X-ray technology developed at the U.S. Department of Energy’s (DOE’s) national laboratories is revealing new insights into diseases ranging… »   

For the first time ever, scientists are using computers and genomic information to predict new uses for existing medicines.

A… »   

U.S. regulators and generic drugmakers have reached a compromise agreement for a user-fee program that would require the companies to… »   

Seattle Genetics’ experimental cancer drug showed promise in treating two rare types of blood cancer, but the design and size… »   

A discovery by University of Alabama at Birmingham researchers about a how a common cell pathway that helps regulate cell… »   

India has promised not to link a proposed trade deal with the European Union with limiting its production of generic… »   

Massachusetts General Hospital (MGH) researchers have discovered the first of an entirely new class of antiangiogenesis drugs – agents that… »   

By accounting for the floppy, fickle nature of RNA, researchers at the University of Michigan and the University of California,… »   

Scientists have made an important step forward in their understanding of cryoprotectants – compounds that act as natural ‘antifreeze’ to… »